Annex Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622K Sell
4,837
-250
-5% -$29.3K 0.01% 233
2026
Q1
$612K Sell
5,087
-165
-3% -$19K 0.01% 229
2025
Q4
$553K Sell
5,252
-1,448
-22% -$136K 0.01% 240
2025
Q3
$562K Sell
6,700
-4,429
-40% -$365K 0.01% 206
2025
Q2
$881K Sell
11,129
-266,571
-96% -$21.2M 0.02% 170
2025
Q1
$24.9M Buy
277,700
+67
+0% +$6.26K 0.71% 44
2024
Q4
$27.6M Sell
277,633
-30,783
-10% -$3.17M 0.83% 28
2024
Q3
$35M Buy
308,416
+39,631
+15% +$4.71M 1.12% 16
2024
Q2
$33.3M Buy
268,785
+24,999
+10% +$3.22M 1.17% 14
2024
Q1
$32.2M Buy
243,786
+25,430
+12% +$3.13M 1.14% 14
2023
Q4
$23.8M Buy
218,356
+35,717
+20% +$3.71M 0.99% 20
2023
Q3
$18.8M Buy
182,639
+31,789
+21% +$3.43M 1.14% 16
2023
Q2
$17.4M Buy
150,850
+2,078
+1% +$236K 0.97% 22
2023
Q1
$15.8M Buy
148,772
+6,412
+5% +$692K 0.85% 20
2022
Q4
$15.8M Buy
142,360
+3,770
+3% +$385K 0.89% 19
2022
Q3
$11.9M Buy
138,590
+3,990
+3% +$356K 0.8% 21
2022
Q2
$12.3M Buy
134,600
+27,146
+25% +$2.41M 0.89% 20
2022
Q1
$8.82M Buy
107,454
+23,962
+29% +$1.89M 0.65% 24
2021
Q4
$6.4M Buy
83,492
+19,931
+31% +$1.59M 0.44% 39
2021
Q3
$4.77M Buy
63,561
+10,235
+19% +$778K 0.39% 43
2021
Q2
$4.14M Buy
53,326
+2,704
+5% +$201K 0.34% 52
2021
Q1
$3.72M Buy
50,622
+3,899
+8% +$288K 0.36% 52
2020
Q4
$3.65M Buy
46,723
+3,782
+9% +$289K 0.36% 45
2020
Q3
$3.4M Sell
42,941
-660
-2% -$51.7K 0.43% 27
2020
Q2
$3.22M Buy
43,601
+39,314
+917% +$2.96M 0.45% 26
2020
Q1
$314K Buy
4,287
+73
+2% +$5.74K 0.04% 98
2019
Q4
$366K Buy
4,214
+405
+11% +$33.3K 0.04% 98
2019
Q3
$306K Buy
3,809
+595
+19% +$47.7K 0.04% 99
2019
Q2
$257K Buy
3,214
+157
+5% +$12K 0.04% 102
2019
Q1
$243K Sell
3,057
-204
-6% -$15.3K 0.04% 107
2018
Q4
$238K Buy
3,261
+104
+3% +$7.34K 0.04% 106
2018
Q3
$214K Sell
3,157
-837
-21% -$53.3K 0.03% 123
2018
Q2
$231K Buy
+3,994
New +$225K 0.04% 116
2017
Q2
Sell
-6,556
Closed -$397K 129
2017
Q1
$397K Sell
6,556
-9,098
-58% -$552K 0.1% 80
2016
Q4
$879K Buy
15,654
+2,749
+21% +$161K 0.21% 39
2016
Q3
$769K Buy
12,905
+244
+2% +$14.3K 0.2% 41
2016
Q2
$696K Buy
12,661
+45
+0.4% +$2.4K 0.19% 49
2016
Q1
$637K Sell
12,616
-624
-5% -$30.6K 0.18% 50
2015
Q4
$667K Buy
13,240
+1,028
+8% +$51.8K 0.2% 47
2015
Q3
$576K Buy
12,212
+2,755
+29% +$146K 0.19% 43
2015
Q2
$514K Buy
9,457
+2,311
+32% +$130K 0.16% 42
2015
Q1
$392K Buy
7,146
+2,149
+43% +$122K 0.13% 52
2014
Q4
$271K Buy
+4,997
New +$278K 0.08% 73

Other funds holding MRK

Annex Advisory Services's MRK Position: Q2 2026 in Review

Annex Advisory Services reduced its Merck (MRK) stake by 4.9% in Q2 2026, selling an estimated $29.3K and leaving 4,837 shares worth $622K. The position accounts for 0.01% of the portfolio, ranked #233.

Annex Advisory Services first reported a position in MRK in Q4 2014 and has held it in 43 quarters since. The position peaked at $35M in Q3 2024. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Annex Advisory Services held 4,837 shares of Merck worth $622K as of Q2 2026.
  • Annex Advisory Services sold 250 Merck shares in Q2 2026, an estimated $29.3K.
  • Merck made up 0.01% of Annex Advisory Services's portfolio in Q2 2026, its #233 holding.
  • Annex Advisory Services first reported a position in Merck in Q4 2014 and has held it in 43 quarters since.
  • Annex Advisory Services's Merck position peaked at $35M in Q3 2024.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Annex Advisory Services's 13F filing for Q2 2026, filed 10 Jul 2026.